Liu L L, Knowlton P W, Svensson C K
Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health Professions, Wayne State University, Detroit, MI 48202.
J Pharm Sci. 1988 Aug;77(8):662-5. doi: 10.1002/jps.2600770804.
We examined the effect of amiodarone on the disposition of procainamide in the rat to determine the mechanism of a reported interaction between amiodarone and procainamide and to determine the effect of amiodarone on drug acetylation. Animals received a 5-d pretreatment with amiodarone hydrochloride (100 mg/kg) or diluent prior to the intravenous administration of 50 mg/kg of procainamide hydrochloride. The plasma clearance, volume of distribution, and half-life of procainamide did not significantly differ between the two groups. The urinary recovery of N-acetylprocainamide was increased by 31% (p less than 0.01) in amiodarone pretreated animals. However, there was no change in the partial clearance of procainamide to N-acetylprocainamide. Neither the renal clearance of procainamide nor N-acetylprocainamide was altered by amiodarone pretreatment. These data suggest that amiodarone interacts with procainamide by reduction of an alternate pathway of elimination, possibly oxidative metabolism.
我们研究了胺碘酮对大鼠体内普鲁卡因胺处置的影响,以确定所报道的胺碘酮与普鲁卡因胺之间相互作用的机制,并确定胺碘酮对药物乙酰化的影响。在静脉注射50mg/kg盐酸普鲁卡因胺之前,动物先接受5天的盐酸胺碘酮(100mg/kg)或稀释剂预处理。两组之间普鲁卡因胺的血浆清除率、分布容积和半衰期没有显著差异。在胺碘酮预处理的动物中,N-乙酰普鲁卡因胺的尿回收率提高了31%(p<0.01)。然而,普鲁卡因胺向N-乙酰普鲁卡因胺的部分清除率没有变化。胺碘酮预处理对普鲁卡因胺和N-乙酰普鲁卡因胺的肾清除率均无影响。这些数据表明,胺碘酮与普鲁卡因胺相互作用的机制可能是通过减少另一种消除途径,可能是氧化代谢。